Showing results (741-750 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|October 27, 2007
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastomaAnna De Geer, Lena-Maria Carlson, Per Kogner, et al.Cancer Immunology, Immunotherapy : CII|July 30, 2008
p27 and salivary cancerOfer Ben-Izhak, Sharon Akrish, Shlomit Gan, et al.Cancer Immunology, Immunotherapy : CII|July 22, 2008
Chordoma and chondrosarcoma gene profile: implications for immunotherapyJoseph H Schwab, Patrick J Boland, Narasimhan P Agaram, et al.Cancer Immunology, Immunotherapy : CII|June 8, 2006
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 moleculesTomoko So, Takeshi Hanagiri, Jacques Chapiro, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Differential diagnosis of histogenetically distinct human epithelial renal tumours with a monoclonal antibody against gamma-glutamyltransferaseP Fischer, S Störkel, W Haase, et al.Cancer Immunology, Immunotherapy : CII|July 5, 2006
CD4 regulatory T cells in human cancer pathogenesisKeith L Knutson, Mary L Disis, Lupe G SalazarCancer Immunology, Immunotherapy : CII|June 6, 2007
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanomaAmir Khammari, Jean-Michel Nguyen, Marie Christine Pandolfino, et al.Cancer Immunology, Immunotherapy : CII|January 24, 2007
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODNSusan de Jong, Ghania Chikh, Laura Sekirov, et al.Cancer Immunology, Immunotherapy : CII|April 20, 2007
DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumorsDae-Seog Lim, Jeong-Hwan Kim, Dong-Seong Lee, et al.Cancer Immunology, Immunotherapy : CII|April 6, 2007
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapyJean-Philippe Theurillat, Ursina Zürrer-Härdi, Zsuzsanna Varga, et al.Pageof 650